← Therapeutics
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
Modafinil Tinnitus Attention Study
Also known as: Modafinil, Modafinil for tinnitus
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Therapeutic
Modality
Small Molecule
Stage
Phase 1
Status
Discontinued
Target Gene
—
Route / Mode
Oral
Confidence
72%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
United States
Population
adult, tinnitus, study-level
Trial IDs
1
Mechanism
Terminated academic Phase 1 crossover-style study of oral modafinil for attention problems associated with tinnitus.
Indications
Notes
ClinicalTrials.gov verifies a terminated University of Arkansas study of modafinil for tinnitus-associated attention problems. It is a historical academic repurposing study, not a current tinnitus product program.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...
IDs: NCT00591019
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-verified-studydiscontinued-registry-studygeneric-drug-studynot-commercial-pipeline-program
Related Programs
PEDMARK by Fennec Pharmaceuticals
Company: Fennec Pharmaceuticals · Small Molecule · Marketed
SENS-401 (Arazasetron) by Sensorion
Company: Sensorion · Small Molecule · Phase 2
AC102 by AudioCure Pharma
Company: AudioCure Pharma · Small Molecule · Phase 2
SPI-1005 by Sound Pharmaceuticals
Company: Sound Pharmaceuticals · Small Molecule · Phase 3
ACOU085 by Acousia Therapeutics
Company: Acousia Therapeutics GmbH · Small Molecule · Phase 2
CIL001 (Paliroden) by Cilcare
Company: Cilcare SAS · Small Molecule · Phase 1/2